Limited significance of the in situ proximity ligation assay
Abstract
In situ proximity ligation assay (isPLA) is an increasingly popular technique that aims at detecting the close proximity of two molecules in fixed samples using two primary antibodies. The maximal distance between the antibodies required for producing a signal is 40 nm, which is lower than optical resolution and approaches the macromolecular scale. Therefore, isPLA may provide refined positional information, and is commonly used as supporting evidence for direct or indirect protein-protein interaction. However, we show here that this method is inherently prone to false interpretations, yielding positive and seemingly specific signals even for totally unrelated antigens. We discuss the difficulty to produce adequate specificity controls. We conclude that isPLA data should be considered with extreme caution.
02 /Specification & Classification
Click any tag to browse matching papers- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Improved method for detecting protein-protein interactions using proximity ligation assay
Zach Tower, Hao Chang·Journal of Proteome ResearchPeer-reviewed·Apr 11, 2025
- Glyceraldehyde-3-Phosphate Dehydrogenase and Seven in Absentia Homolog -1 Interactions in Mammalian Cells Visualized Using Proximity Ligation Assay
Harkewal Singh, Christopher Melm·bioRxiv·Nov 30, 2016
- Optimizing In Situ Proximity Ligation Assays for Mitochondria, ER, or MERC Markers in Skeletal Muscle Tissue and Cells
D. C. Stephens, A. Crabtree, … A. Hinton·bioRxiv·May 20, 2023
- HiPLA: High-throughput imaging Proximity Ligation Assay
L. Serebryannyy, T. Misteli·bioRxiv·Jul 17, 2018
- Spatial mapping of proteins and their activity states in cancer models by multiplex in situ PLA
Liza Löf, Bo Xu, … Ulf D. Landegren·bioRxiv·Jul 11, 2025
- Sensitive protein detection using site-specifically oligonucleotide-conjugated nanobodies
R. A. Al-Amin, P. M. Muthelo, … U. Landegren·bioRxiv·Jan 10, 2022